Nachrichten

BEQ: Volume 15, Number 4 – October 2005

SPECIAL ISSUE: ETHICAL RESPONSIBILITIES REGARDING DRUGS, PATENTS, AND HEALTH

  • Michael P. Ryan, Introduction
  • Richard T. DeGeorge, Intellectual Property and Pharmaceutical Drugs: An Ethical Analysis
  • Klaus M. Leisinger, The Corporate Social Responsibility of the Pharmaceutical Industry: Idealism Without Illusions and Realism Without Resignation
  • Patricia H. Werhane and Michael Gorman, Intellectual Property Rights, Moral Imagination, and Access to Life ­Enhancing Drugs

  • Articles

  • J. Lawrence French and Richard E. Wokutch, Child Workers, Globalization and Intellectual Business Ethics: A Case Study in Brazil’s Export-Oriented Shoe Industry
  • Richard Hudson, Ethical Investing: Ethical Investors and Managers
  • Geoff Moore, Corporate Character: Modern Virtue Ethics and the Virtuous Corporation
  • Henry J. Van Buren III, An Employee-Centered Model of Corporate Social Performance
  • Review Articles

  • Jeffrey Smith, Stakeholder Theory and Organizational Ethics and Unfolding Stakeholder Thinking
  • Laura Spence, Business Ethics: A European Perspective. Managing Corporate Citizenship and Sustainability in The Age of Globalization